Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.16 - $0.34 $12 - $26
78 Added 0.89%
8,858 $1,000
Q4 2022

Feb 14, 2023

BUY
$0.22 - $15.3 $565 - $39,305
2,569 Added 41.36%
8,780 $2,000
Q3 2022

Nov 14, 2022

SELL
$0.0 - $21.78 $0 - $257,657
-11,830 Reduced 65.57%
6,211 $1,000
Q2 2022

Aug 15, 2022

SELL
$0.0 - $0.0 $0 - $0
-1,324 Reduced 6.84%
18,041 $8,000
Q1 2022

May 16, 2022

BUY
$0.0 - $0.0 $0 - $0
17,365 Added 868.25%
19,365 $20,000
Q4 2021

Feb 14, 2022

SELL
$0.0 - $6.95 $0 - $71,932
-10,350 Reduced 83.81%
2,000 $2,000
Q3 2021

Nov 15, 2021

SELL
$0.0 - $7.49 $0 - $80,075
-10,691 Reduced 46.4%
12,350 $26,000
Q2 2021

Aug 16, 2021

BUY
$7.46 - $9.49 $171,885 - $218,659
23,041 New
23,041 $67,000

Others Institutions Holding YCBD

About cbdMD, Inc.


  • Ticker YCBD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,555,600
  • Market Cap $27.3M
  • Description
  • cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...
More about YCBD
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.